{"transactions":[{"id":2739880,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":140046,"kind":"person","name":"Weiss Lawrence Martin","position":1,"cik":"0001761625","reported_name":"Weiss Lawrence Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-26T21:48:52.000Z","date":"2021-04-22","kind":"exercise","acquired":false,"shares":9378,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On March 2, 2020, Dr. Weiss was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date."}],"balance_after":28136,"derivative":{"exercise_price":28.33,"expiration_date":"2027-03-02","underlying":"Common Stock","underlying_shares":9378},"source":{"system":"sec-edgar","filing":"0001077183-21-000113","document":"wf-form4_161947371579723.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000113/wf-form4_161947371579723.xml","form_type":"4"}},{"id":2739879,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":140046,"kind":"person","name":"Weiss Lawrence Martin","position":1,"cik":"0001761625","reported_name":"Weiss Lawrence Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-26T21:48:52.000Z","date":"2021-04-22","kind":"exercise","acquired":false,"shares":9005,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 1, 2019, Dr. Weiss was granted 36,022 stock options. These options vest ratably over the first four anniversary dates of the grant date."}],"balance_after":18012,"derivative":{"exercise_price":19.6,"expiration_date":"2024-03-01","underlying":"Common Stock","underlying_shares":9005},"source":{"system":"sec-edgar","filing":"0001077183-21-000113","document":"wf-form4_161947371579723.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000113/wf-form4_161947371579723.xml","form_type":"4"}},{"id":2739878,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":140046,"kind":"person","name":"Weiss Lawrence Martin","position":1,"cik":"0001761625","reported_name":"Weiss Lawrence Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-26T21:48:52.000Z","date":"2021-04-22","kind":"exercise","acquired":false,"shares":6667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On April 19, 2018, Dr. Weiss was granted 20,000 stock options. These options vested ratably over the first three anniversary dates of the grant date."}],"balance_after":0,"derivative":{"exercise_price":9.22,"expiration_date":"2023-04-19","underlying":"Common Stock","underlying_shares":6667},"source":{"system":"sec-edgar","filing":"0001077183-21-000113","document":"wf-form4_161947371579723.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000113/wf-form4_161947371579723.xml","form_type":"4"}},{"id":2739877,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":140046,"kind":"person","name":"Weiss Lawrence Martin","position":1,"cik":"0001761625","reported_name":"Weiss Lawrence Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-26T21:48:52.000Z","date":"2021-04-22","kind":"exercise","acquired":true,"shares":9378,"price":28.33,"value":265678.74,"ownership":{"direct":true},"balance_after":130847,"source":{"system":"sec-edgar","filing":"0001077183-21-000113","document":"wf-form4_161947371579723.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000113/wf-form4_161947371579723.xml","form_type":"4"}},{"id":2739876,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":140046,"kind":"person","name":"Weiss Lawrence Martin","position":1,"cik":"0001761625","reported_name":"Weiss Lawrence Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-26T21:48:52.000Z","date":"2021-04-22","kind":"exercise","acquired":true,"shares":9005,"price":19.6,"value":176498.0,"ownership":{"direct":true},"balance_after":121469,"source":{"system":"sec-edgar","filing":"0001077183-21-000113","document":"wf-form4_161947371579723.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000113/wf-form4_161947371579723.xml","form_type":"4"}},{"id":2739875,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":140046,"kind":"person","name":"Weiss Lawrence Martin","position":1,"cik":"0001761625","reported_name":"Weiss Lawrence Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-26T21:48:52.000Z","date":"2021-04-22","kind":"exercise","acquired":true,"shares":6667,"price":9.22,"value":61469.74,"ownership":{"direct":true},"balance_after":112464,"source":{"system":"sec-edgar","filing":"0001077183-21-000113","document":"wf-form4_161947371579723.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000113/wf-form4_161947371579723.xml","form_type":"4"}},{"id":2815548,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":140046,"kind":"person","name":"Weiss Lawrence Martin","position":1,"cik":"0001761625","reported_name":"Weiss Lawrence Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-04T01:16:10.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":29895,"price":53.17,"value":1589517.15,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On March 2, 2021, Dr. Weiss was granted 29,895 stock options. These options vest ratably over the first four anniversary dates of the grant date."}],"balance_after":29895,"derivative":{"exercise_price":53.17,"expiration_date":"2028-03-02","underlying":"Common Stock","underlying_shares":29895},"source":{"system":"sec-edgar","filing":"0001077183-21-000079","document":"wf-form4_161482054396633.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000079/wf-form4_161482054396633.xml","form_type":"4"}},{"id":2815547,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":140046,"kind":"person","name":"Weiss Lawrence Martin","position":1,"cik":"0001761625","reported_name":"Weiss Lawrence Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-03-04T01:16:10.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":5276,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":105797,"source":{"system":"sec-edgar","filing":"0001077183-21-000079","document":"wf-form4_161482054396633.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000079/wf-form4_161482054396633.xml","form_type":"4"}},{"id":2945091,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":140046,"kind":"person","name":"Weiss Lawrence Martin","position":1,"cik":"0001761625","reported_name":"Weiss Lawrence Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-16T01:51:33.000Z","date":"2020-12-14","kind":"exercise","acquired":false,"shares":9005,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On March 1, 2019, Dr. Weiss was granted 36,022 stock options. These options vest ratably over the first four anniversary dates of the grant date."}],"balance_after":27017,"derivative":{"exercise_price":19.6,"expiration_date":"2024-03-01","underlying":"Common Stock","underlying_shares":9005},"source":{"system":"sec-edgar","filing":"0001077183-20-000227","document":"wf-form4_160808347590230.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718320000227/wf-form4_160808347590230.xml","form_type":"4"}},{"id":2945090,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":140046,"kind":"person","name":"Weiss Lawrence Martin","position":1,"cik":"0001761625","reported_name":"Weiss Lawrence Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-16T01:51:33.000Z","date":"2020-12-14","kind":"exercise","acquired":false,"shares":16666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On December 12, 2018, Dr. Weiss was granted 25,000 stock options. These options vest ratably over the first three anniversary dates of the grant date."}],"balance_after":8334,"derivative":{"exercise_price":13.87,"expiration_date":"2023-12-12","underlying":"Common Stock","underlying_shares":16666},"source":{"system":"sec-edgar","filing":"0001077183-20-000227","document":"wf-form4_160808347590230.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718320000227/wf-form4_160808347590230.xml","form_type":"4"}},{"id":2945089,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":140046,"kind":"person","name":"Weiss Lawrence Martin","position":1,"cik":"0001761625","reported_name":"Weiss Lawrence Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-16T01:51:33.000Z","date":"2020-12-14","kind":"exercise","acquired":false,"shares":13333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On April 19, 2018, Dr. Weiss was granted 20,000 stock options. These options vest ratably over the first three anniversary dates of the grant date."}],"balance_after":6667,"derivative":{"exercise_price":9.22,"expiration_date":"2023-04-19","underlying":"Common Stock","underlying_shares":13333},"source":{"system":"sec-edgar","filing":"0001077183-20-000227","document":"wf-form4_160808347590230.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718320000227/wf-form4_160808347590230.xml","form_type":"4"}},{"id":2945088,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":140046,"kind":"person","name":"Weiss Lawrence Martin","position":1,"cik":"0001761625","reported_name":"Weiss Lawrence Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-16T01:51:33.000Z","date":"2020-12-14","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 25, 2017, Dr. Weiss was granted 20,000 stock options. These options vested ratably over the first three anniversary dates of the grant date."}],"balance_after":0,"derivative":{"exercise_price":7.27,"expiration_date":"2022-05-25","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001077183-20-000227","document":"wf-form4_160808347590230.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718320000227/wf-form4_160808347590230.xml","form_type":"4"}},{"id":2945087,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":140046,"kind":"person","name":"Weiss Lawrence Martin","position":1,"cik":"0001761625","reported_name":"Weiss Lawrence Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-16T01:51:33.000Z","date":"2020-12-14","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 1, 2016, Dr. Weiss was granted 50,000 stock options. These options vested ratably over the first three anniversary dates of the grant date."}],"balance_after":0,"derivative":{"exercise_price":6.98,"expiration_date":"2021-03-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001077183-20-000227","document":"wf-form4_160808347590230.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718320000227/wf-form4_160808347590230.xml","form_type":"4"}},{"id":2945086,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":140046,"kind":"person","name":"Weiss Lawrence Martin","position":1,"cik":"0001761625","reported_name":"Weiss Lawrence Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-12-16T01:51:33.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":20200,"price":51.06,"value":1031412.0,"ownership":{"direct":true},"balance_after":100521,"source":{"system":"sec-edgar","filing":"0001077183-20-000227","document":"wf-form4_160808347590230.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718320000227/wf-form4_160808347590230.xml","form_type":"4"}},{"id":2945085,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":140046,"kind":"person","name":"Weiss Lawrence Martin","position":1,"cik":"0001761625","reported_name":"Weiss Lawrence Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-12-16T01:51:33.000Z","date":"2020-12-14","kind":"exercise","acquired":true,"shares":9005,"price":19.6,"value":176498.0,"ownership":{"direct":true},"balance_after":120721,"source":{"system":"sec-edgar","filing":"0001077183-20-000227","document":"wf-form4_160808347590230.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718320000227/wf-form4_160808347590230.xml","form_type":"4"}},{"id":2945084,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":140046,"kind":"person","name":"Weiss Lawrence Martin","position":1,"cik":"0001761625","reported_name":"Weiss Lawrence Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-12-16T01:51:33.000Z","date":"2020-12-14","kind":"exercise","acquired":true,"shares":16666,"price":13.87,"value":231157.42,"ownership":{"direct":true},"balance_after":111716,"source":{"system":"sec-edgar","filing":"0001077183-20-000227","document":"wf-form4_160808347590230.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718320000227/wf-form4_160808347590230.xml","form_type":"4"}},{"id":2945083,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":140046,"kind":"person","name":"Weiss Lawrence Martin","position":1,"cik":"0001761625","reported_name":"Weiss Lawrence Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-12-16T01:51:33.000Z","date":"2020-12-14","kind":"exercise","acquired":true,"shares":13333,"price":9.22,"value":122930.26,"ownership":{"direct":true},"balance_after":95050,"source":{"system":"sec-edgar","filing":"0001077183-20-000227","document":"wf-form4_160808347590230.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718320000227/wf-form4_160808347590230.xml","form_type":"4"}},{"id":2945082,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":140046,"kind":"person","name":"Weiss Lawrence Martin","position":1,"cik":"0001761625","reported_name":"Weiss Lawrence Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-12-16T01:51:33.000Z","date":"2020-12-14","kind":"exercise","acquired":true,"shares":20000,"price":7.27,"value":145400.0,"ownership":{"direct":true},"balance_after":81717,"source":{"system":"sec-edgar","filing":"0001077183-20-000227","document":"wf-form4_160808347590230.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718320000227/wf-form4_160808347590230.xml","form_type":"4"}},{"id":2945081,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":140046,"kind":"person","name":"Weiss Lawrence Martin","position":1,"cik":"0001761625","reported_name":"Weiss Lawrence Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-12-16T01:51:33.000Z","date":"2020-12-14","kind":"exercise","acquired":true,"shares":50000,"price":6.98,"value":349000.0,"ownership":{"direct":true},"balance_after":61717,"source":{"system":"sec-edgar","filing":"0001077183-20-000227","document":"wf-form4_160808347590230.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718320000227/wf-form4_160808347590230.xml","form_type":"4"}},{"id":3234159,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":140046,"kind":"person","name":"Weiss Lawrence Martin","position":1,"cik":"0001761625","reported_name":"Weiss Lawrence Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-03-04T01:06:20.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":37514,"price":28.33,"value":1062771.62,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On March 2, 2020, Dr. Weiss was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date."}],"balance_after":37514,"derivative":{"exercise_price":28.33,"exercise_date":"2021-03-02","expiration_date":"2027-03-02","underlying":"Common Stock","underlying_shares":37514},"source":{"system":"sec-edgar","filing":"0001077183-20-000033","document":"wf-form4_158328396163882.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718320000033/wf-form4_158328396163882.xml","form_type":"4"}},{"id":3234158,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":140046,"kind":"person","name":"Weiss Lawrence Martin","position":1,"cik":"0001761625","reported_name":"Weiss Lawrence Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-03-04T01:06:20.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":5824,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11717,"source":{"system":"sec-edgar","filing":"0001077183-20-000033","document":"wf-form4_158328396163882.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718320000033/wf-form4_158328396163882.xml","form_type":"4"}},{"id":3614789,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":140046,"kind":"person","name":"Weiss Lawrence Martin","position":1,"cik":"0001761625","reported_name":"Weiss Lawrence Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-05T21:47:12.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":36022,"price":19.6,"value":706031.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 1, 2019, Dr. Weiss was granted an option to purchase shares of NeoGenomics, Inc. common stock. The option vests ratably over the first four anniversary dates of the grant date."}],"balance_after":36022,"derivative":{"exercise_price":19.6,"exercise_date":"2020-03-01","expiration_date":"2024-03-01","underlying":"Common Stock","underlying_shares":36022},"source":{"system":"sec-edgar","filing":"0001077183-19-000025","document":"wf-form4_155182241852994.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718319000025/wf-form4_155182241852994.xml","form_type":"4"}},{"id":3614788,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":140046,"kind":"person","name":"Weiss Lawrence Martin","position":1,"cik":"0001761625","reported_name":"Weiss Lawrence Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-03-05T21:47:12.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":5893,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5893,"source":{"system":"sec-edgar","filing":"0001077183-19-000025","document":"wf-form4_155182241852994.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718319000025/wf-form4_155182241852994.xml","form_type":"4"}},{"id":3731149,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":140046,"kind":"person","name":"Weiss Lawrence Martin","position":1,"cik":"0001761625","reported_name":"Weiss Lawrence Martin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-14T21:35:16.000Z","date":"2018-12-12","kind":"grant","acquired":true,"shares":25000,"price":13.87,"value":346750.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On December 12, 2018, Dr. Weiss was granted an option to purchase shares of NeoGenomics, Inc. common stock.  The option vests ratably over the first three anniversary dates of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":13.87,"exercise_date":"2019-12-12","expiration_date":"2023-12-12","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001077183-18-000149","document":"wf-form4_154482329833504.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718318000149/wf-form4_154482329833504.xml","form_type":"4"}}]}